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ABSTRACT 
In this research work we have derived three dimensional (3D) structure of α-glucosidase enzyme through homology modeling and 
the predicted structure was validated with the help of PROCHECK analysis in the form of Ramachandran plot. According to 
Ramachandran plot statistics the derived model was found to be of good quality.  
 
Cite this article as: Sainy N, Dubey N, In-silico homology modeling and validation of α-glucosidase enzyme, Journal of Drug 
Delivery and Therapeutics. 2017; 7(7):126-127 
 
INTRODUCTION: 
Diabetes mellitus type 2, include 90% of all cases of 
diabetes mellitus is increasing considerably and 
affecting about 5% of the world population. The burden 
of diabetes is driven by vascular complications such as 
cardiovascular disease, stroke, nephropathy, retinopathy 
and renal failure. Type 2 diabetes mellitus is often 
associated with abnormalities in plasma lipid and 
lipoprotein profiles, and postprandial hyperlipidemia has 
been shown to be an independent risk factor and 
predictor of atherosclerosis
1-2
. α-glucosidase inhibitors 
delay carbohydrate digestion and prolong overall 
carbohydrate digestion time, causing a reduction in the 
rate of glucose absorption and consequently blunting the 
postprandial plasma glucose rise.
 
Thus inhibition of 
enzyme α-glucosidase is a new and promising approach 
for the treatment of diabetes mellitus.  
MATERIAL AND METHODS: 
As the crystal structure of α-glucosidase enzyme is not 
available in the protein data bank (PDB), therefore the 
3D structure of α-glucosidase was derived through 
homology modeling. The protein sequence (FASTA 
sequence) of enzyme α-glucosidase was retrieved from 
Uniprot/Swissprot database. The sequence was 
submitted to modweb
3
 web server to find a suitable 
template with sufficient query sequence coverage and 
sequence identity. The model derived through modweb 
web server was selected on the basis of maximum 
sequence similarity (46.00 %) with the template (crystal 
structure of Human intestinal maltase-glucoamylase; 
PDB code: 2qmjA)
4
. 
RESULT AND DISCUSSION: 
Structure of modeled enzyme (Figure 1) was validated 
through PROCHECK analysis. For this analysis, the 
PDB format file of modeled α-glucosidase enzyme was 
submitted to PDB SUM web server of European 
Bioinformatics Institute. The results of PROCHECK 
analysis was obtained in the form of Ramachandran plot 
(Figure 2) which resolve stereo chemical aspects along 
with main chain and side chain parameters with 
widespread analysis. The Ramachandran plot 
(PROCHECK) statistics are summarized in Table 1.  
 
Figure 1: 3D structure of derived model of α-
glucosidase enzyme
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Figure 2: Ramachandran plot of homology modeled α-glucosidase enzyme 
Table 1: Ramachandran plot (PROCHECK) Statistics of homology modeled α-glucosidase enzyme 
Residue No. of  residues                              Percentage 
Most favoured regions      [A,B,L] 631 87.0% 
Additional allowed regions [a,b,l,p] 77 10.6% 
Generously allowed regions [~a,~b,~l,~p] 11 1.5% 
Disallowed regions 6 0.8% 
Non-glycine and non-proline residues 725 100.0% 
End-residues (excl. Gly and Pro) 2 
 
Glycine residues 67 
Proline residues 69 
Total number of residues 863 
 
CONCLUSION: 
In this research work we have successfully derived the 
3D structure of enzyme α-glucosidase.  The modeled 
enzyme was validated through PROCHECK analysis 
(Ramachandran plot). The Ramachandran plot indicated 
that phi (φ) and psi(ψ)  angles to contribute in 
conformations of amino acids excluding glycine and 
proline with 87.0 % residues in most favored region, 
10.6 % in additional allowed region, 1.5 % in 
generously allowed region and 0.8 % residues in 
disallowed region. The above statistics of 
Ramachandran plot indicated that derived model was 
found to be of good quality and can be used for further 
molecular modeling study. 
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